aceRNA Technologies
About:
aceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.
Website: https://acernatec.com/
Top Investors: SMBC Venture Capital, Kyoto University Innovation Capital, Hidetoshi Takano, Hirofumi Miki
Description:
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
Total Funding Amount:
282M JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Kyoto, Kyoto, Japan
Founded Date:
2018-04-01
Contact Email:
info(AT)acernatec.com
Founders:
Shin Teruo
Number of Employees:
11-50
Last Funding Date:
2020-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai